
The article outlines two options-based 'YieldBoost' strategies for TG Therapeutics (TGTX), currently trading at $32.98, leveraging its elevated implied volatility. Selling a $32.00 strike put for a $5.80 premium offers an effective acquisition cost of $26.20 if assigned, or a 27.80% annualized return if the option expires worthless (64% probability). Concurrently, a covered call strategy, selling a $34.00 strike call for $6.30, yields a 22.20% total return if shares are called away by May 2026, or a 29.30% annualized premium boost if the call expires worthless (40% probability).
The options market for TG Therapeutics (TGTX), currently trading at $32.98, presents significant premium-selling opportunities driven by elevated implied volatility. Specifically, implied volatility for the analyzed put and call contracts stands at 67% and 71% respectively, notably higher than the stock's trailing twelve-month actual volatility of 59%. This dislocation allows for attractive 'YieldBoost' strategies. Selling the May 2026 $32.00 put contract at a $5.80 bid creates an effective cost basis of $26.20 if assigned, a substantial discount to the current share price. Alternatively, if the option expires worthless, which has a 64% probability, it generates a 27.80% annualized return on the cash commitment. For existing shareholders, a covered call strategy involving the May 2026 $34.00 strike offers a $6.30 premium. This caps the total return at 22.20% if the stock is called away, but provides a 29.30% annualized premium boost if the option expires worthless, an event with a 40% probability.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment